Back

Genetic variability in PAR4 platelet response in relation to bleeding and ischemic outcomes: a genetic substudy of the TRACER trial.

28 August 2017 (11:36 - 11:45)
Organised by:
Congress Presentation Part of: Drug treatment of acute coronary syndrome patients Thrombosis and platelets ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Pierluigi Tricoci

Duke University Medical Center, Durham (United States of America)

8 More presentations in this session

Presentation thumbnail
New use of low-dose aspirin and risk of intracerebral haemorrhage, subdural haematoma and subarachnoid haemorrhage: associations by sex, case-fatality and trauma status in a large observational study.
Doctor L. Garcia Rodriguez (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Antiplatelet effects of oral P2Y12-receptor inhibitor loading strategies for transitioning from cangrelor
Assistant Professor W. Hochholzer (Wurzburg, DE)
Abstract Slides Video
Presentation thumbnail
G-CSF effects on left ventricular function assessed with standard echocardiographic evaluation (biplane EF) and 2D myocardial strain in patients with STEMI and LV dysfunction
Doctor S. Righetti (Monza, IT)
Abstract Slides Video
Presentation thumbnail
Ticagrelor improves cardiac function and post-myocardial infarction healing: cardiac magnetic resonance imaging assessment of functional, anatomical and remodeling parameters.
Doctor G. Mendieta Badimon (Barcelona, ES)
Abstract
Presentation thumbnail
Effectiveness and safety of ticagrelor compared with clopidogrel and prasugrel: results from a cohort study in the nationwide french claims and hospitalisation database (SNIIRAM)
Professor N. Danchin (Paris, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Drug treatment of acute coronary syndrome patients

The Event

Event poster

ESC Congress 2017

28 August 2017 11:36 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources